SPL 0.00% 9.9¢ starpharma holdings limited

Ann: DEP irinotecan clinical data presented at AACR meeting, page-19

  1. 9,372 Posts.
    lightbulb Created with Sketch. 863
    " I think we are in for some VERY challenging times ahead. Remember though the SP Floor will be $0.085 based off cash in bank."


    That cash is not static as it is constantly being committed forward and with less qualifying research less will come back as rebate .

    IMO you nee to tak out 6-9 months forward cash from any possible valuation as so much expenditire is committed and any downscale comes with cosst like retrenchment etc etc. Just my thoughts but it is a big organisation with constant outgoings including building move reno etc

 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.